DV
Dividend Vision

AURX — Nuo Therapeutics Inc

Nuo Therapeutics Inc (AURX)

Total return is -61.5% over the past 9.5 years, 347.3 points behind SPY at 285.8%. Its deepest 1-year drawdown was 74.3%.

AURX appears to be a single-stock equity holding rather than a diversified ETF fund, tracking Nuo Therapeutics Inc, a healthcare company. The listing lacks standard ETF characteristics such as a defined distribution frequency, yield rate, and expense ratio, suggesting this may be a data classification issue or a specialized security structure. Investors should verify the current fund structure and objectives, as the available information does not align with typical dividend-focused ETF profiles.

AURX key facts

Asset type
Stock
Asset class
Equity
Inception date
02/14/2017
Distribution frequency
None
Last close
$0.77
Market cap
$37,274,720
Average volume
4904.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.04